Company Filing History:
Years Active: 1996
Title: The Innovative Contributions of Perry Newman, III
Introduction
Perry Newman, III is a notable inventor based in Odenton, MD (US). He has made significant contributions to the field of biotechnology, particularly through his innovative designs in bioreactor technology. His work has implications for various applications, including retroviral vector and animal cell culture production.
Latest Patents
Perry Newman, III holds a patent for a bioreactor that features a stainless steel column housing capped with an O-ring sealed cover. This design forms a sealed autoclavable sterile chamber, which is essential for maintaining sterile conditions during biological processes. The bioreactor includes a pair of stainless steel mesh circular cylindrical concentric inner and outer columns, with a bed of porous glass spherical beads packed in the region between them. The system is designed to monitor and control pH and dissolved oxygen levels while continuously supplying culture medium to and from the sterile chamber. The outer mesh column creates an outer bulk medium chamber, while the inner mesh column forms an inner bulk medium chamber. A ring sparger introduces a mixture of air and CO₂ into the outer bulk medium chamber, generating pressure differentials that facilitate bulk medium flow through the packed bead bed. This innovative design allows for efficient culture processes without pressure gradients in the bead bed.
Career Highlights
Perry Newman, III is currently associated with Genetic Therapy, Inc., where he continues to develop and refine biotechnological solutions. His expertise in bioreactor design has positioned him as a key player in the field, contributing to advancements in cell culture technologies.
Collaborations
Throughout his career, Perry has collaborated with esteemed colleagues such as Shuyuan Zhang and Hitoshi Kotani. These partnerships have fostered a collaborative environment that enhances innovation and research in biotechnology.
Conclusion
Perry Newman, III's contributions to bioreactor technology exemplify the impact of innovative thinking in biotechnology. His patented designs and ongoing work at Genetic Therapy, Inc. continue to advance the field, showcasing the importance of creativity and collaboration in scientific research.